Clinical Trial Update: Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia [NA]

View source ↗

Summary

A clinical trial (S1904) from Peking University People's Hospital is investigating whether to bridge to allogeneic hematopoietic stem cell transplantation after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR-T cell therapy (CAR-T cell therapy targeting CD19)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Relapsed Adult ALL, B-cell Acute Lymphoblastic Leukemia | NA | Status: RECRUITING